Ovarian Cysts |
|
|
Benign ovarian cyst An ovarian cyst is any collection of fluid within the ovary. Some of these, called functional cysts, are part of the normal process of menstruation. Any ovarian follicle that is larger than about 2 centimeters is termed an ovarian cyst. Specific types of cyst include graafian follicles (which may rupture at mid-cycle and cause mittelschmerz) or corpus luteum cysts (which may rupture about the time of menstruation, and take up to three months to disappear entirely). ...
Wikipedia - [full article]
Ovarian Cysts Clinical Trials
- Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts
ClinicalTrials.gov Identifier: NCT00459641 - Recruiting
Bone Cysts
- Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
ClinicalTrials.gov Identifier: NCT00001912 - Active, not recruiting
Cysticercosis; Cysts; Seizures
- Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission
ClinicalTrials.gov Identifier: NCT00002977 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; stage IV ovarian epithelial cancer; ...
- Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003322 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ...
- Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00002568 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; ovarian endometrioid adenocarcinoma; ...
- TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00022347 - Active, not recruiting
ovarian serous cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ...
- Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
ClinicalTrials.gov Identifier: NCT00002538 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; stage I ovarian epithelial cancer; ...
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00005026 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00017303 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00003967 - Active, not recruiting
ovarian serous cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ...
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003944 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00005612 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00002717 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00021385 - Active, not recruiting
recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; stage IV ovarian germ cell tumor; ...
- Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients
ClinicalTrials.gov Identifier: NCT00127920 - Active, not recruiting
Ovarian Neoplasms
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00004221 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00002477 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer
- Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00101257 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00003413 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003297 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00004166 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003733 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003532 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; ...
- Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00034151 - Active, not recruiting
Ovarian Cancer
- Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects with Relapsed or Refractory Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00113789 - Active, not recruiting
Ovarian Cancer
- Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00006230 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
- Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00052468 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003358 - Active, not recruiting
recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; ...
- Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003345 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; ...
- Study of T900607-sodium in previously treated patients with ovarian cancer.
ClinicalTrials.gov Identifier: NCT00043446 - Active, not recruiting
Ovarian Neoplasms
- Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00028743 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
- National Ovarian Cancer Early Detection Program Screening and Genetic Study
ClinicalTrials.gov Identifier: NCT00005095 - Recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003214 - Active, not recruiting
Ovarian Cancer
- 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00081276 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
- Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00038428 - Active, not recruiting
Ovarian Neoplasms
- TLK286 in Combination with Doxil in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00052065 - Active, not recruiting
Ovarian Neoplasms
- Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00058435 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; ...
- Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
ClinicalTrials.gov Identifier: NCT00003160 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
- Quality-of-Life Assessment in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003772 - Active, not recruiting
recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
- Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00066729 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; ...
- Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00006942 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- TLK286 in Combination with Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00051948 - Active, not recruiting
Ovarian Neoplasms
- Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00003998 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00041080 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00030706 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00031954 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
ovarian epithelial cancer
- Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00021034 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- OVCA-NAC-P2: Study of Chemotherapy followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers
ClinicalTrials.gov Identifier: NCT00112086 - Active, not recruiting
Ovarian Neoplasms; Fallopian Tube Neoplasms
- Hormone Therapy With LY353381 Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003670 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
- Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00036751 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- A Study to Evaluate the effect of HER2 Activation on rhuMAb 2C4 (pertuzumab) in Subjects with Advanced Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00058552 - Active, not recruiting
Ovarian Cancer
- Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
ClinicalTrials.gov Identifier: NCT00003120 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
- Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00004876 - Recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00004064 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003892 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003378 - Active, not recruiting
peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00563836 - Recruiting
Ovarian Cancer; Epithelial Ovarian Cancer
- Second-Line Treatment for Patients with Platinum-Sensitive Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00090610 - Recruiting
Ovarian Cancer
- Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00053833 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; ...
- Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00155896 - Recruiting
Ovarian Cancer
- Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003450 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
- Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00022659 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00026091 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00010179 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ...
- A Study Comparing the Combination of Doxil and Yondelis, to Doxil Alone for Subjects with Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00113607 - Active, not recruiting
Ovarian Cancer
- High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00003425 - Active, not recruiting
Leukemia; Bone Cancer; ovarian sarcoma; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma
- Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00004083 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00011986 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
- Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00075543 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00400348 - Active, not recruiting
Ovarian Cancer
- MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00401674 - Active, not recruiting
Ovarian Cancer
- Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00428766 - Active, not recruiting
Epithelial Ovarian Cancer
- Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
ClinicalTrials.gov Identifier: NCT00507780 - Recruiting
Ovarian Function; Preservation of Ovarian Function
- A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
ClinicalTrials.gov Identifier: NCT00421889 - Recruiting
Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer
- Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
ClinicalTrials.gov Identifier: NCT00377429 - Active, not recruiting
Ovarian Cancer
- A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00096993 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- OCSTUD Docetaxel+Cisplatin+Cyclophosphamide Versus Docetaxel+Carboplatin in Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00452985 - Active, not recruiting
Ovarian Neoplasms
- Taxol Carboplatin and Erythropoetin
ClinicalTrials.gov Identifier: NCT00158379 - Active, not recruiting
Ovarian Cancer
- Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00170573 - Active, not recruiting
Ovarian Cancer
- Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003449 - Active, not recruiting
recurrent ovarian epithelial cancer
- Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00006454 - Active, not recruiting
stage II ovarian epithelial cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003644 - Active, not recruiting
ovarian epithelial cancer
- Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00016224 - Active, not recruiting
recurrent ovarian epithelial cancer
- Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003695 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer
- Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00511992 - Recruiting
Advanced Ovarian Carcinoma; Primary Peritoneal Carcinoma; Ovarian Carcinosarcoma
- High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery
ClinicalTrials.gov Identifier: NCT00004921 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- CA-125 in Screening Patients at High Risk for Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00080639 - Active, not recruiting
ovarian epithelial cancer
- Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
ovarian epithelial cancer
- Study of XL999 in Patients With Previously Treated Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00277290 - Active, not recruiting
Ovarian Cancer
- Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
ClinicalTrials.gov Identifier: NCT00017134 - Active, not recruiting
ovarian epithelial cancer
- OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00382811 - Recruiting
Fallopian Tube Cancer; Peritoneal Neoplasms; Ovarian Cancer
- IGFBP-3 in Ovarian Cancer Invasion
ClinicalTrials.gov Identifier: NCT00154986 - Recruiting
Ovarian Carcinoma
- Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00004206 - Active, not recruiting
recurrent ovarian epithelial cancer
- Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
ClinicalTrials.gov Identifier: NCT00228319 - Active, not recruiting
Ovarian Cancer
- CT-2106 for the Second Line Treatment of Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00291837 - Active, not recruiting
Ovarian Cancer
Resources
- ACOG's Physician Directory (American College of Obstetricians and Gynecologists)
- Atlas of the Body: Female Reproductive Organs (American Medical Association)

Not Signed In -

